Streetbeat News

Stock Prices

PSTG

Barclays analyst Tim Long has downgraded Pure Storage (NYSE:PSTG) from Overweight to Equal-Weight while maintaining the price target at $51.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 12:59 pm

SPY

The USA Redbook year-over-year (YoY) growth rate has decreased to 5.5% from the previous 6.3%.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 12:56 pm

KEYS

Keysight Technologies (NYSE: KEYS) reported better-than-expected Q2 earnings, with adjusted earnings of $1.41 per share and sales of $1.216 billion. The company expects Q3 revenue of $1.18 billion to $1.20 billion and adjusted earnings of $1.30 to $1.36 per share. Analysts revised their price targets, with Baird increasing to $167 and Susquehanna decreasing to $195.

Portfolio Pulse from Avi Kapoor

May 21, 2024 | 12:55 pm

AEIS

PSCT

RNMC

XPPLF

Advanced Energy Industries, Inc. (NASDAQ:AEIS) has disclosed a new offer to acquire XP Power Ltd. (OTC:XPPLF) for £19.50 per share in cash, reflecting a significant premium over XP Power's recent share prices. The total proposed consideration is £571 million. This is the fourth offer made by Advanced Energy, with previous offers being rejected by XP Power's board. The acquisition is expected to expand Advanced Energy's product portfolio and technical capabilities.

Portfolio Pulse from Lekha Gupta

May 21, 2024 | 12:55 pm

SCNI

Trading halt status was updated at 8:55:00 AM ET, indicating a resumption of quotations. The news and resumption times are provided.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 12:55 pm

LYRA

Trading for LYRA was halted at 8:55:00 a.m. ET due to pending news.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 12:55 pm

SILO

Silo Pharma has reported results from a study on a new drug formulation for depression treatment, which shows potential in extending remission periods and preventing relapse in patients.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 12:48 pm

ABT

BROS

GOOS

MGTX

NTNX

Jim Cramer provided stock recommendations on CNBC's 'Mad Money Lightning Round.' He recommended buying Dutch Bros Inc. (NYSE:BROS) and Nutanix, Inc. (NASDAQ:NTNX), while advising caution on Abbott Laboratories (NYSE:ABT) and Canada Goose Holdings Inc. (NYSE:GOOS). He also called MeiraGTx Holdings plc (NASDAQ:MGTX) a 'worthy spec.'

Portfolio Pulse from Avi Kapoor

May 21, 2024 | 12:44 pm

BDRX

MMAT

SPT

Market-Moving News for May 21st includes significant updates for Biodexa Pharmaceuticals, Meta Materials, and Sprout Social. Biodexa Pharmaceuticals reported positive Phase 2 clinical trial results, Meta Materials announced potential legal action for market manipulation, and Sprout Social clarified that there is no plan to sell or take the company private.

Portfolio Pulse from ryanfaloona@benzinga.com

May 21, 2024 | 12:42 pm

PALI

Palisade Bio's PALI-2108 shows promising preclinical results in mouse models for Ulcerative Colitis, demonstrating safety, efficacy, and local bioactivation. The company plans to start Phase 1 human trials by the end of the year.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 12:41 pm